Circulating levels of free insulin-like growth factors in obese subjects: The impact of type 2 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 15, Issue 5, 1999, Pages 314-322

  Frystyk, J ^a   Skjaerbaek C ^a   Vestbo, E ^a   Fisker, S ^a   Orskov H ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Diabetes; Free IGF I; Free IGF II; GHBP; IGFs; Obesity

Indexed keywords

GROWTH HORMONE BINDING PROTEIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REGRESSION ANALYSIS;

ANALYSIS OF VARIANCE; BODY MASS INDEX; BODY WEIGHT; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; OBESITY; REFERENCE VALUES; REGRESSION ANALYSIS;

EID: 0032721646     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-7560(199909/10)15:5<314::AID-DMRR56>3.0.CO;2-E     Document Type: Article

References (49)

1. Baxter RC. Insulin-like growth factor binding proteins in the human circulation: a review. Horm Res 1994; 42: 140-144.
2. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994; 15: 80-101.
3. Rasmussen MH, Frystyk J, Andersen T, Breum L, Christiansen JS, Hilsted J. The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone. Metabolism 1994; 43: 315-319.
4. Frystyk J, Vestbo E, Skjærbæk C, Mogensen CE, Ørskov H. Free insulin-like growth factors in human obesity. Metabolism 1995; 44 (Suppl 4): 37-44.
5. Nam SY, Lee EJ, Kim KR et al. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord 1997; 21: 355-359.
6. Argente J, Caballo N, Barrios V et al. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction. J Clin Endocrinol Metab 1997; 82: 2076-2083.
7. Rasmussen MH, Ho KK, Kjems L, Hilsted J. Serum growth hormone-binding protein in obesity: effect of a short-term, very low calorie diet and diet-induced weight loss. J Clin Endocrinol Metab 1996; 81: 1519-1524.
8. Brismar K, Fernqvist Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab 1994; 79: 872-878.
9. Lee PD, Giudice LC, Conover CA, Powell DR. Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med 1997; 216: 319-357.
10. Conover CA, Lee PD, Kanaley JA, Clarkson JT, Jensen MD. Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. J Clin Endocrinol Metab 1992; 74: 1355-1360.
11. Rajkumar K, Barron D, Lewitt MS, Murphy LJ. Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. Endocrinology 1995; 136: 4029-4034.
12. Cox GN, McDermott MJ, Merkel E et al. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats. Endocrinology 1994; 135: 1913-1920.
13. Baxter RC. Insulin-like growth factor binding proteins as glucoregulators. Metabolism 1995; 44 (Suppl 4): 12-17.
14. Frystyk J, Hussain MA, Skjærbæk C et al. Serum free IGF-I during a hyperinsulinemic clamp following three days of administration of IGF-I versus saline. Am J Physiol 1997; 273: E507-E513.
15. Frystyk J, Grøfte T, Skjærbæk C, Ørskov H. The effect of oral glucose on serum free insulin-like growth factor-I and -II in healthy adults. J Clin Endocrinol Metab 1997; 82: 3124-3127.
16. Frystyk J, Grønbaek H, Skjærbæk C, Flyvbjerg A, Ørskov H, Baxter RC. Developmental changes in serum levels of free and total insulin-like growth factor-I (IGF-I), IGF-binding protein-1 and -3 and the acid labile subunit in rats. Endocrinology 1998; 139: 4286-4292.
17. Frystyk J, Dinesen B, Ørskov H. Non-competitive time-resolved immunofluorometric assay for determination of human insulin-like growth factor I and II. Growth Regul 1995; 5: 169-176.
18. Frystyk J, Skjærbæk C, Dinesen B, Ørskov H. Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett 1994; 348: 185-191.
19. Fisker S, Frystyk J, Skriver L, Vestbo E, Ho KKY, Ørskov H. A simple, rapid immunometric assay for determination of functional and growth hormone-occupied growth hormone-binding protein in human serum. Eur J Clin Invest 1996; 26: 779-785.
20. Arnfred J, Schmitz O, Hother-Nielsen O, et al. Marked impairment of the effect of hyperglycaemia on glucose uptake and glucose production in insulin-dependent diabetes. Diabetic Med 1988; 5: 755-760.
21. Lee PD, Powell D, Baker B et al. Characterization of a direct, non-extraction immunoradiometric assay for free IGF-I. Proc 76th Ann Meeting Endocrine Soc 1994; Abstract 939.
22. Janssen JA, Jacobs ML, Derkx FH, Weber RF, van der Lely AJ, Lamberts SW. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997; 82: 2809-2815.
23. Juul A, Flyvbjerg A, Frystyk J, Müller J, Skakkebæk NE. Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins -1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty. Clin Endocrinol (Oxf) 1996; 44: 515-523.
24. Gibson JM, Westwood M, Crosby SR et al. Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin dependent diabetes mellitus. J Clin Endocrinol Metab 1995; 80: 1369-1375.
25. Bang P, Brismar K, Rosenfeld RG, Hall K. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects. J Clin Endocrinol Metab 1994; 78: 960-967.
26. Hilding A, Brismar K, Degerblad M, Thoren M, Hall K. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. J Clin Endocrinol Metab 1995; 80: 2646-2652.
27. Batch JA, Baxter RC, Werther G. Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes. J Clin Endocrinol Metab 1991; 73: 964-968.
28. Poulos JE, Leggett Frazier N, Khazanie P et al. Circulating insulin-like growth factor I concentrations in clinically severe obese patients with and without NIDDM in response to weight loss. Horm Metab Res 1994; 26: 478-480.
29. Bach LA, Rechler MM. Insulin-like growth factors and diabetes. Diabetes Metab Rev 1992; 8: 229-257.
30. Kaal A, Frystyk J, Skjærbæk C et al. Effects of intramuscular microsphere-encapsulated octreotide on serum growth hormone, insulin-like growth factors (IGFs), free IGFs, and IGF-binding proteins in acromegalic patients. Metabolism 1995; 44 (Suppl 1): 6-14.
31. Skjærbæk C, Frystyk J, Møller J, Christiansen JS, Ørskov H. Free and total insulin-like growth factor-I and insulin-like growth factor-binding proteins during 14 days of growth hormone administration in healthy adults. Eur J Endocrinol 1996; 135: 672-677.
32. Frystyk J, Skjærbæk C, Zapf J, Ørskov H. Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia. Diabetologia 1998; 41: 589-594.
33. Daughaday WH, Trivedi B, Baxter RC. Abnormal serum IGF-II transport in non-islet cell tumor hypoglycemia results from abnormalities of both IGF binding protein-3 and acid labile subunit and leads to elevation of free IGF-II. Endocrine 1995; 3: 425-430.
34. Strasser-Vogel B, Blum WF, Past R et al. Insulin-like growth factor (IGF)-I and -II and IGF-binding proteins-1, -2, and -3 in children and adolescents with diabetes mellitus: correlation with metabolic control and height attainment. J Clin Endocrinol Metab 1995; 80: 1207-1213.
35. Blum WF, Horn N, Kratzsch J et al. Clinical studies of IGFBP-2 by radioimmunoassay. Growth Regul 1993; 3: 100-104.
36. Bereket A, Lang CH, Blethen SL, Wilson TA. Insulin-like growth factor-binding protein-2 and insulin: studies in children with type 1 diabetes mellitus and maturity-onset diabetes of the young. J Clin Endocrinol Metab 1995; 80: 3647-3652.
37. Schwander J, Mary JL. The RIA for IGFBP-2 in man - a meagre catch? Growth Regul 1993; 3: 104-108.
38. Clemmons DR, Snyder DK, Busby WHJ. Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects. J Clin Endocrinol Metab 1991; 73: 727-733.
39. Riedel M, Hoeft B, Blum WF, von zur Muhlen A, Brabant G. Pulsatile growth hormone secretion in normal-weight and obese men: differential metabolic regulation during energy restriction. Metabolism 1995; 44: 605-610.
40. Holman SR, Baxter RC. Insulin-like growth factor binding protein-3: factors affecting binary and ternary complex formation. Growth Regul 1996; 6: 42-47.
41. Davenport ML, Svoboda ME, Koerber KL, van Wyk JJ, Clemmons DR, Underwood LE. Serum concentrations of insulin-like growth factor II are not changed by short-term fasting and refeeding. J Clin Endocrinol Metab 1988; 67: 1231-1236.
42. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995; 16: 3-34.
43. Barnard R, Waters MJ. The serum growth hormone binding protein: pregnant with possibilities. J Endocrinol 1997; 153: 1-14.
44. Kratzsch J, Keliner K, Zilkens T, Schmidt Gayk H, Selisko T, Scholz GH. Growth hormone-binding protein related immunoreactivity is regulated by the degree of insulinopenia in diabetes mellitus. Clin Endocrinol (Oxf) 1996; 44: 673-678.
45. Mercado M, Molitch ME, Baumann G. Low plasma growth hormone binding protein in IDDM. Diabetes 1992; 41: 605-609.
46. Massa G, Dooms L, Bouillon R, Vanderschueren Lodeweyckx M. Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 239-243.
47. Mercado M, Baumann G. Characteristics of the somatotropic axis in insulin dependent diabetes mellitus. Arch Med Res 1995; 26: 101-109.
48. Glass AR, Burman KD, Dahms WT, Boehm TM. Endocrine function in human obesity. Metabolism 1981; 30: 89-104.
49. Chapman IM, Hartman ML, Pieper KS et al. Recovery of growth hormone release from suppression by exogenous insulin-like growth factor-I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I. J Clin Endocrinol Metab 1998; 83: 2836-2842.